Sfoglia per Autore
Perspectives on hiPSC-derived muscle cells as drug discovery models for muscular dystrophies
2021 E. Abati, E. Sclarandi, G.P. Comi, V. Parente, S. Corti
Impact of COVID-19 on the quality of life of patients with neuromuscular disorders in the Lombardy area, Italy
2021 D. Gagliardi, G. Costamagna, E. Abati, E. Mauri, R. Brusa, L. Scudeller, L. Andreoli, G. Citterio, E. Piccin, F. Magri, M. Meneri, D. Velardo, M. Sciacco, N. Bresolin, S. Corti, G.P. Comi
Adeno-Associated Virus (AAV)-mediated gene therapy for Duchenne muscular dystrophy : the issue of transgene persistence
2022 A. Manini, E. Abati, A. Nuredini, S. Corti, G.P. Comi
Mitochondrial DNA homeostasis impairment and dopaminergic dysfunction : a trembling balance
2022 A. Manini, E. Abati, G.P. Comi, S. Corti, D. Ronchi
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
2022 E. Abati, A. Manini, D. Velardo, R. Del Bo, L. Napoli, F. Rizzo, M. Moggio, N. Bresolin, E. Bellone, M.T. Bassi, M.G. D'Angelo, G.P. Comi, S. Corti
Inhibition of myostatin and related signaling pathways for the treatment of muscle atrophy in motor neuron diseases
2022 E. Abati, A. Manini, G.P. Comi, S. Corti
A cross-sectional survey study of the impact of COVID-19 pandemic on the training and quality of life of Italian medical residents in the Lombardy region
2022 E. Abati, L. Nelva Stellio, A. Manini, F. Moroni, L. Azzalini, L.M. Vilca
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
2023 M. Meneri, E. Abati, D. Gagliardi, I. Faravelli, V. Parente, A. Ratti, F. Verde, N. Ticozzi, G.P. Comi, L. Ottoboni, S. Corti
Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study
2023 I. Faravelli, D. Gagliardi, E. Abati, M. Meneri, J. Ongaro, F. Magri, V. Parente, L. Petrozzi, G. Ricci, F. Farè, G. Garrone, M. Fontana, D. Caruso, G. Siciliano, G.P. Comi, A. Govoni, S. Corti, L. Ottoboni
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A
2023 F. Rizzo, S. Bono, M.D. Ruepp, S. Salani, L. Ottoboni, E. Abati, V. Melzi, C. Cordiglieri, S. Pagliarani, R. De Gioia, A. Anastasia, M. Taiana, M. Garbellini, S. Lodato, P. Kunderfranco, D. Cazzato, D. Cartelli, C. Lonati, N. Bresolin, G. Comi, M. Nizzardo, S. Corti
Charcot-Marie-Tooth type 2A in vivo models: Current updates
2024 E. Abati, M. Rizzuti, A. Anastasia, G.P. Comi, S. Corti, F. Rizzo
Shaping the Neurovascular Unit Exploiting Human Brain Organoids
2024 M. Rizzuti, V. Melzi, L. Brambilla, L. Quetti, L. Sali, L. Ottoboni, M. Meneri, A. Ratti, F. Verde, N. Ticozzi, G.P. Comi, S. Corti, E. Abati
Sleep and sleep-related breathing disorders in patients with spinal muscular atrophy: a changing perspective from novel treatments?
2024 E. Abati, E. Mauri, M. Rimoldi, B. Madini, F. Patria, G.P. Comi, S. Corti
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives
2024 C. Alberti, F. Rizzo, A. Anastasia, G. Comi, S. Corti, E. Abati
IN VIVO AND IN VITRO EVALUATION OF THE COMBINATION OF RNA INTERFERING AND GENE THERAPY FOR TREATING MITOFUSIN2-RELATED DISEASES
2024 E. Abati
Cardiac risk and myocardial fibrosis assessment with cardiac magnetic resonance in patients with myotonic dystrophy
2024 E. Abati, C. Alberti, V. Tambè, A. Esseridou, G.P. Comi, S. Corti, G. Meola, F. Secchi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile